Nike Looks Cheap, But You Have to Believe the Shoemaker can "Just Do It"

Nike’s fiscal Q3 2026 sales were flat year over year and margins declined, but the U.S. market showed an encouraging 6% increase in shoe sales, suggesting early traction in the company’s "Win Now" turnaround. The stock has fallen more than 70% from its 2021 high, yet it still offers a 3.5% dividend yield and continues its annual dividend growth streak. Management says the turnaround is not finished, but improving U.S. trends and historically cheap valuation metrics support a cautiously constructive view.

Analysis

The key setup is less about a clean fundamentals bottom and more about an inflection in expectations. When a category leader is marked down this far, the stock can rerate quickly on evidence that the core market is stabilizing, because the market stops discounting perpetual share loss and starts capitalizing normalized margins again. That makes the U.S. sales rebound disproportionately important: if domestic wholesale and direct channels are both improving, it suggests the company is repairing the two layers of the business that matter most for durability—sell-through and retailer trust.

The second-order winner is likely the broader athletic-footwear ecosystem, not just the stock. If the turnaround takes hold, suppliers and brand-adjacent distributors may see replenishment orders improve before headline revenue accelerates, while rivals with cleaner inventories face tougher comps and potentially more promotional pressure. Conversely, a failed turnaround would likely hit the whole category with another round of discounting, so the trade is really a bet on whether Nike can reclaim pricing power without leaning on the balance sheet.

The consensus seems to underappreciate how much optionality is embedded in the current valuation if operating leverage turns even modestly positive. Earnings are the wrong metric to anchor on here because they can stay noisy through restructuring, but a normalized revenue base paired with modest gross margin recovery can produce outsized EPS torque over the next 2-4 quarters. The dividend helps support the stock, but the real catalyst is evidence that the turnaround is self-funding rather than requiring continued promotional intensity.

Risk remains that this is a multi-quarter repair job and the market gets impatient before the data improves. If U.S. sell-through stalls again, the multiple can compress further because the bull case depends on trust returning, not just cost cuts. The cleanest contrary signal would be a reacceleration in domestic footwear, followed by margins holding up as restructuring costs roll off over the next two reported quarters.

Key Decisions for Investors

• Go long NKE on a 3-6 month horizon only on confirmation of continued U.S. footwear improvement; target a rerating toward historical valuation bands if revenue inflects and margin pressure eases.
• For a lower-risk expression, buy NKE call spreads 6-9 months out rather than stock; the payoff is tied to a turnaround rerating while capping downside if execution slips.
• Pair trade: long NKE / short a lower-quality apparel or footwear peer with weaker balance-sheet flexibility and higher promo exposure over the next 2 quarters; the thesis is that a leader’s recovery will pull share from weaker competitors first.
• If already long, use the high dividend as carry but define a stop on any renewed deterioration in U.S. unit trends; the stock’s downside is most sensitive to another quarter of failed sell-through, not to macro noise.
• Do not chase on a one-quarter bounce; wait for two consecutive quarters of domestic stabilization before adding size, because the market will likely fade a single data point.